Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
24,11 USD | +2,03 % | +20,67 % | +13,57 % |
16/04 | XENCOR, INC. : recomendación de compra de BTIG | ZM |
09/04 | Xencor nombra a Bart Cornelissen director financiero | MT |
Resumen de negocios
Número de empleados: 280
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Monoclonal Bispecific Antibody and Cytokine Therapeutics
100,0
%
| 165 | 100,0 % | 168 | 100,0 % | +2,28 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Global
100,0
%
| 165 | 100,0 % | 168 | 100,0 % | +2,28 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Bassil Dahiyat
FOU | Founder | 53 | 01/08/97 |
John Desjarlais
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/07/01 |
Charles Liles
IRC | Investor Relations Contact | - | - |
Jennifer Sandoz
HRO | Human Resources Officer | - | - |
Celia Eckert
LAW | General Counsel | 52 | 10/09/19 |
Jeremy Grunstein
PRN | Corporate Officer/Principal | - | 23/05/19 |
David Szymkowski
PRN | Corporate Officer/Principal | 60 | 01/01/02 |
Raphael Clynes
PRN | Corporate Officer/Principal | - | 08/06/17 |
Nancy Valente
PRN | Corporate Officer/Principal | 66 | 08/09/22 |
Dane Leone
PRN | Corporate Officer/Principal | - | 02/01 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Kevin Gorman
BRD | Director/Board Member | 66 | 14/04/17 |
Director/Board Member | 71 | 19/12/17 | |
Director/Board Member | 70 | 18/03/15 | |
Bassil Dahiyat
FOU | Founder | 53 | 01/08/97 |
Kurt Gustafson
BRD | Director/Board Member | 56 | 25/07/14 |
69 | - | ||
Barbara Klencke
BRD | Director/Board Member | 66 | 15/09/23 |
Director/Board Member | 60 | 18/12/19 | |
Nancy Valente
PRN | Corporate Officer/Principal | 66 | 08/09/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 61 647 493 | 61 064 703 ( 99,05 %) | 0 | 99,05 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
INMUNE BIO, INC. 10.46% | 1 885 533 | 10.46% | 22 155 013 $ |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+13,57 % | 1486,32 M | |
-1,43 % | 104 mil M | |
+8,96 % | 105 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+6,79 % | 14,16 mil M | |
+38,61 % | 12,63 mil M |
- Bolsa de valores
- Acciones
- Acción XNCR
- Empresa Xencor, Inc.